MET and breast cancer: Although these data do not allow definitive conclusions, they demonstrate a crucial role of the HGF/c-MET pathway in tumor cell proliferation and clinical behavior and highlight the need for additional investigations on its molecular mechanism in order to promote both the development of anti-MET targeted therapies and the generation of a new prognostic score and decisional algorithm in BC.